Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled fenfluramine study in Rett syndrome
MOH_2026-07-19_016945Phase 3Not yet recruiting
- Sponsor
- UCB
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Rett syndrome (RTT) comparing Fenfluramine hydrochloride with Matching placebo (2 arms). Planned start Jun 2026; status: not yet recruiting.
02
Drugs
fenfluramine
03
Conditions
Rett syndrome (RTT)
Beyond the preview
Go deeper on MOH_2026-07-19_016945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2026-07-19_016945.